Mixed Hepatocelllar‐Cholangiocarcinoma: Is it Time to Rethink Consideration for Liver Transplantation?
Recognition of a mixed hepatocellular‐cholangiocarcinoma (HCC‐CCA) in a candidate is generally considered a contraindication to liver transplantation (LT) due to a perception of poor posttransplant survival and high recurrence rates.1 Due to the relative rarity of these tumors and a lack of widely accepted and consistent diagnostic criteria, there is little published data to guide transplant consideration.
This article is protected by copyright. All rights reserved.
Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.
Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.